KT-333, A First-in-Class STAT3 Degrader, Caused Strong STAT3 Degradation and Consistent Downstream Biology In Vitro and In Vivo

October 19, 2022

20th Annual Discovery on Target Conference

Disocvery on Target
Area of Focus
Oncology
Programs
STAT3 (KT-333)
Indications
Liquid Tumors Solid Tumors
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link